- -

Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam

Mostrar el registro sencillo del ítem

Ficheros en el ítem

dc.contributor.author Peña-Mendizábal, Edurne es_ES
dc.contributor.author Morais, Sergi es_ES
dc.contributor.author Maquieira Catala, Ángel es_ES
dc.date.accessioned 2021-11-05T12:57:54Z
dc.date.available 2021-11-05T12:57:54Z
dc.date.issued 2020-09-29 es_ES
dc.identifier.issn 2045-2322 es_ES
dc.identifier.uri http://hdl.handle.net/10251/176180
dc.description.abstract [EN] New antigens deriving from -lloyl and -llanyl, major and minor determinants, respectively, were produced for beta-lactam antibiotics cefuroxime, cefotaxime, ceftriaxone, meropenem and aztreonam. Twenty beta-lactam antigens were produced using human serum albumin and histone H1 as carrier proteins. Antigens were tested by multiplex in vitro immunoassays and evaluated based on the detection of specific IgG and IgE in the serum samples. Both major and minor determinants were appropriate antigens for detecting specific anti-beta-lactam IgG in immunised rabbit sera. In a cohort of 37 allergic patients, we observed that only the minor determinants (-llanyl antigens) were suitable for determining specific anti-beta-lactam IgE antibodies with high sensitivity (<0.01 IU/mL; 24 ng/L) and specificity (100%). These findings reveal that not only the haptenisation of beta-lactam antibiotics renders improved molecular recognition events when the 4-member beta-lactam ring remains unmodified, but also may contribute to develop promising minor antigens suitable for detecting specific IgE-mediated allergic reactions. This will facilitate the development of sensitive and selective multiplexed in vitro tests for drug-allergy diagnoses to antibiotics cephalosporin, carbapenem and monobactam. es_ES
dc.description.sponsorship This work has been funded by the H2020 programme (Project COBIOPHAD, grant agreement No. 688448), and is an initiative of the Photonics Public Private Partnership (www.photonics21.org); Agencia Estatal de Investigacion (CTQ2016-75749-R, FEDER) and programme UPV-LA FE 2019 (PI05 VALBIOAL). The authors acknowledge the Instituto de Investigacion Sanitaria La Fe, Valencia, Spain, which provided the samples from both allergic patients and controls. E.P.M acknowledges an FPU grant from the Ministerio de Educacion, Cultura y Deporte. es_ES
dc.language Inglés es_ES
dc.publisher Nature Publishing Group es_ES
dc.relation.ispartof Scientific Reports es_ES
dc.rights Reconocimiento (by) es_ES
dc.subject.classification QUIMICA ANALITICA es_ES
dc.title Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.1038/s41598-020-73109-w es_ES
dc.relation.projectID info:eu-repo/grantAgreement/EC/H2020/688448/EU/COMPACT BIOPHOTONIC PLATFORM FOR DRUG ALLERGY DIAGNOSIS/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/AEI//CTQ2016-75749-R//BIOSENSORES HOLOGRAFICOS. PRUEBA DE CONCEPTO Y DEMOSTRACION EN APLICACIONES CLINICAS/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/UNIVERSIDAD POLITECNICA DE VALENCIA//UPV-FE-PI05//VALIDACION DE UN SISTEMA BIOFOTONICO PARA EL DIAGNOSTICO IN VITRO DE ALERGIA A ANTIBIOTICOS/ es_ES
dc.rights.accessRights Abierto es_ES
dc.contributor.affiliation Universitat Politècnica de València. Departamento de Química - Departament de Química es_ES
dc.description.bibliographicCitation Peña-Mendizábal, E.; Morais, S.; Maquieira Catala, Á. (2020). Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam. Scientific Reports. 10(1):1-12. https://doi.org/10.1038/s41598-020-73109-w es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion https://doi.org/10.1038/s41598-020-73109-w es_ES
dc.description.upvformatpinicio 1 es_ES
dc.description.upvformatpfin 12 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 10 es_ES
dc.description.issue 1 es_ES
dc.identifier.pmid 32994501 es_ES
dc.identifier.pmcid PMC7525514 es_ES
dc.relation.pasarela S\418574 es_ES
dc.contributor.funder European Commission es_ES
dc.contributor.funder Agencia Estatal de Investigación es_ES
dc.contributor.funder European Regional Development Fund es_ES
dc.contributor.funder UNIVERSIDAD POLITECNICA DE VALENCIA es_ES
dc.contributor.funder Ministerio de Educación, Cultura y Deporte es_ES
dc.description.references Klein, E. Y. et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc. Natl. Acad. Sci. U.S.A. 115, E3463–E3470 (2018). es_ES
dc.description.references Torres, M. J. et al. Controversies in drug allergy: Beta-lactam hypersensitivity testing. J. Allergy Clin. Immunol. Pract. 7, 40–45 (2019). es_ES
dc.description.references Fontaine, C. et al. Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate β-lactam allergy. Allergy Eur. J. Allergy Clin. Immunol. 62, 47–52 (2007). es_ES
dc.description.references Romano, A. & Gue, R. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann. Intern. Med. 141, 16–22 (2004). es_ES
dc.description.references Caimmi, S., Bousquet-rouanet, L. & Arnoux, B. Safety of cefuroxime as an alternative in patients with a proven hypersensitivity to penicillins: A DAHD cohort survey. Int. Arch. Allergy Immunol. 153, 53–60 (2010). es_ES
dc.description.references Chandel, A. K., Rao, L. V., Narasu, M. L. & Singh, O. V. The realm of penicillin G acylase in β-lactam antibiotics. Enzyme Microb. Technol. 42, 199–207 (2008). es_ES
dc.description.references Gruchalla, R. S. Drug allergy. J. Allergy Clin. Immunol. 111, 548–559 (2003). es_ES
dc.description.references Warrington, R. & Silviu-dan, F. Drug allergy. Allergy Asthma Clin. Immunol. 7, S10 (2011). es_ES
dc.description.references Page, M. G. P. Beta-lactam antibiotics. In Antibiotic Discovery and Development (eds Dougherty, T. J. & Pucci, M. J.) 79–117 (Springer, Boston, 2012). es_ES
dc.description.references World Health Organization. WHO Report on Surveillance of Antibiotic Consumption: 2016–2018 Early implementation (World Health Organization, Geneva, 2018). es_ES
dc.description.references European Centre for Disease Prevention and Control. In Antimicrobial Consumption in the EU/EEA, Annual Epidemiological Report for 2018. (2019). es_ES
dc.description.references Frumin, J. & Gallagher, J. C. Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: What are the chances?. Ann. Pharmacother. 43, 304–315 (2009). es_ES
dc.description.references Baldo, B. A. Penicillins and cephalosporins as allergens—Structural aspects of recognition and cross-reactions. Clin. Exp. Allergy 29, 744–749 (1999). es_ES
dc.description.references Adkinson, N. F., Mendelson, L. M., Ressler, C. & Keogh, J. C. Penicillin minor determinants: History and relevance for current diagnosis. Ann. Allergy Asthma Immunol. 121, 537–544 (2018). es_ES
dc.description.references Blanca, M. et al. Side-chain-specific reactions to betalactams: 14 years later. Clin. Exp. Allergy 32, 192–197 (2002). es_ES
dc.description.references Ho, H. P. et al. Identification of new minor metabolites of penicillin G in human serum by multiple-stage tandem mass spectrometry. Rapid Commun. Mass Spectrom. 25, 25–32 (2011). es_ES
dc.description.references Bousquet, P. J., Co-Minh, H. B., Arnoux, J. P. & Daures, P. J. D. Importance of mixture of minor determinants and benzylpenicilloyl poly-l-lysine skin testing in the diagnosis of b-lactam allergy. J. Allergy Clin. Immunol. 115, 1314–1316 (2005). es_ES
dc.description.references Anderson, J. A. Allergic and allergic-like reactions to drugs and other therapeutic agents. In Current Clinical Practice: Allergic Diseases—Diagnosis and Treatment (eds Lieberman, P. & Anderson, J. A.) 295–318 (Humana Press, Totowa, 2007). es_ES
dc.description.references Romano, A. et al. Cross-reactivity and tolerability of aztreonam and cephalosporins in subjects with a T cell-mediated hypersensitivity to penicillins. J. Allergy Clin. Immunol. 138, 179–186 (2016). es_ES
dc.description.references Geng, B., Eastman, J. J., Mori, K., Braskett, M. & Riedl, M. A. Utility of minor determinants for skin testing in inpatient penicillin allergy evaluation. Ann. Allergy Asthma Immunol. 119, 258–261 (2017). es_ES
dc.description.references Atanasković-Marković, M. et al. Tolerability of meropenem in children with IgE-mediated hypersensitivity to penicillins. Allergy Eur. J. Allergy Clin. Immunol. 63, 237–240 (2008). es_ES
dc.description.references Demoly, P. & Romano, A. Update on beta-lactam allergy diagnosis. Curr. Allergy Asthma Rep. 5, 9–14 (2005). es_ES
dc.description.references Doña, I., Torres, M. J., Montañez, M. I. & Fernández, T. D. In vitro diagnostic testing for antibiotic allergy. Allergy Asthma Immunol. Res. 9, 288–298 (2017). es_ES
dc.description.references Marwood, J., Aguirrebarrena, G., Kerr, S., Welch, S. A. & Rimmer, J. De-labelling self-reported penicillin allergy within the emergency department through the use of skin tests and oral drug provocation testing. Emerg. Med. Australas. 29, 509–515 (2017). es_ES
dc.description.references Baldo, B. A., Zhao, Z. & Pham, N. H. Structural determinants of antibiotic allergy. Curr. Allergy Rep. 1, 23–31 (2001). es_ES
dc.description.references Hermanson, G. T. Bioconjugate Techniques (Academic Press, Cambridge, 2013). es_ES
dc.description.references Pham, N. H. & Baldo, B. A. β-lactam drug allergens: Fine structural recognition patterns of cephalosporin-reactive IgE antibodies. J. Mol. Recogn. 9, 287–296 (2002). es_ES
dc.description.references Zhao, Z., Batley, M., D’Ambrosio, C. & Baldo, B. A. In vitro reactivity of penicilloyl and penicillanyl albumin and polylysine conjugates with IgE-antibody. J. Immunol. Methods 242, 43–51 (2000). es_ES
dc.description.references Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254 (1976). es_ES
dc.description.references Wang, Y., He, C. H., Zheng, H. & Zhang, H. B. Characterization and comparison of fumonisin B1-protein conjugates by six methods. Int. J. Mol. Sci. 13, 84–96 (2012). es_ES
dc.description.references Hawkes, R., Niday, E. & Gordon, J. A dot-lmmunobinding assay for monoclonal and other antibodies. Anal. Biochem. 119, 142–147 (1982). es_ES
dc.description.references Badran, A. A., Morais, S. & Maquieira, Á. Simultaneous determination of four food allergens using compact disc immunoassaying technology. Anal. Bioanal. Chem. 409, 2261–2268 (2017). es_ES
dc.description.references Dobosz, P., Morais, S., Bonet, E., Puchades, R. & Maquieira, Á. Massive immuno multiresidue screening of water pollutants. Anal. Chem. 87, 9817–9824 (2015). es_ES
dc.description.references Belliveau, P. P. Omalizumab: a monoclonal anti-IgE antibody. MedGenMed 7, 27 (2005). es_ES
dc.description.references Zhang, Z. et al. Enhanced sensitivity of capture IgE-ELISA based on a recombinant Der f 1/2 fusion protein for the detection of IgE antibodies targeting house dust mite allergens. Mol. Med. Rep. 19, 3497–3504 (2019). es_ES
dc.description.references Baldo, B. A., Zhao, Z. & Pham, N. H. Antibiotic allergy: Immunochemical and clinical considerations. Curr. Allergy Asthma Rep. 8, 49–55 (2008). es_ES
dc.description.references Takeuchi, Y., Inoue, T. & Sunagawa, M. Studies on the structures of meropenem (SM-7338) and it’s primary metabolite. J. Antibiotech. (Tokyo) 46, 827–832 (1992). es_ES
dc.description.references Lambert, D. G. Drugs and receptors. Contin. Educ. Anaesth. Crit. Care Pain 4, 181–184 (2004). es_ES
dc.description.references Torres, M. J. & Blanca, M. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 58, 961–972 (2003). es_ES
dc.description.references Van Boeckel, T. P. et al. Global antibiotic consumption 2000 to 2010: An analysis of national pharmaceutical sales data. Lancet Infect. Dis. 14, 742–750 (2014). es_ES
dc.description.references Gueant, J.-L., Gueant-Rodriguez, R.-M., Viola, M., Luigi Valluzzi, R. & Romano, A. IgE-mediated hypersensitivity to cephalosporins. Curr. Pharm. Des. 12, 3335–3345 (2006). es_ES
dc.description.references Har, D. & Solensky, R. Penicillin and beta-lactam hypersensitivity. Immunol. Allergy Clin. N. Am. 37, 643–662 (2017). es_ES
dc.description.references Romano, A., Gaeta, F., Poves, M. F. A. & Valluzzi, R. L. Cross-reactivity among beta-lactams. Curr. Allergy Asthma Rep. 16, 1–12 (2016). es_ES
dc.description.references Madaan, A. & Li, J. T. C. Cephalosporin allergy. Immunol. Allergy Clin. N. Am. 24, 463–476 (2004). es_ES
dc.description.references Lemke, T. L., Williams, D. A., Roche, V. F. & Zito, S. W. Foye’s Principles of Medicinal Chemistry (Lippincott Williams & Wilkins, Philadelphia, 2013). es_ES
dc.description.references Blanca-Lopez, N. et al. Allergic reactions to penicillins and cephalosporins: Diagnosis, assessment of cross-reactivity and management. Expert Rev. Clin. Immunol. 15, 707–721 (2019). es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem